http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114748458-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c460cd619c2b29ea173a5dae6c7aec2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2022-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3428f0ac97a9293e73e06dd164c5e4a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee86641dd422cd1a92eaf01886c7e960 |
| publicationDate | 2022-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114748458-A |
| titleOfInvention | Application of propranolol in anti-coronavirus infection |
| abstract | The invention discloses the application of propranolol and its derivatives or pharmaceutically acceptable salts thereof in preparing medicines for preventing or treating coronavirus infection. The study of the present invention shows that propranolol can effectively inhibit or degrade virus replication organelles and inhibit virus replication, and it has clear and significant preventive effects on coronaviruses including SARS-CoV-2, SARS-CoV and MERS-CoV It can alleviate many diseases caused by the sequelae of the new coronavirus. At the same time, the present invention also discloses that propranolol and its derivatives or pharmaceutically acceptable salts thereof are used in the preparation of prevention or treatment in combination with other anti-new coronavirus drugs, including those that have been approved for marketing or have entered the clinic. Application of Coronavirus Infection Drugs. In combination, low doses can significantly reduce viral load. This has great application and promotion significance for the current treatment and prevention of novel coronavirus COVID‑19. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023034282-A1 |
| priorityDate | 2022-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.